Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.
about
Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populationsPharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunologyDecrease in penicillin susceptibility due to heat shock protein ClpL in Streptococcus pneumoniae.In vitro characterization of aminoglycoside adaptive resistance in Pseudomonas aeruginosa.Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis modelAdaptive resistance in bacteria requires epigenetic inheritance, genetic noise, and cost of efflux pumpsPharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.Dynamic Proteome Response of Pseudomonas aeruginosa to Tobramycin Antibiotic Treatment.Aminoglycoside resistance in Pseudomonas aeruginosa.Individualized drug and dose: the clinical pharmacologist's calling or curse?Non-inherited antibiotic resistance.Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence.Pharmacological considerations for the proper clinical use of aminoglycosides.Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.Adaptive resistance to antibiotics in bacteria: a systems biology perspective.Regulation of antimicrobial resistance by extracytoplasmic function (ECF) sigma factors.Intraosseous gentamicin perfusion of the distal metacarpus in standing horses.MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides.Improved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitro.Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their postantibiotic effects.Efficacies of different vancomycin dosing regimens against Staphylococcus aureus determined with a dynamic in vitro model.Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants.Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy.The place of tobramycin in lower respiratory tract infections (LRTI).Once-daily gentamicin administration for community-associated methicillin resistant Staphylococcus aureus in an in vitro pharmacodynamic model: preliminary reports for the advantages for optimizing pharmacodynamic index.A comparison of two amikacin dosing regimens in paediatric surgical patients.Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosa.Phenotypic persistence and external shielding ultraviolet radiation inactivation kinetic model.Aminoglycosides in hemodialysis patients: is the current practice of post dialysis dosing appropriate?Influence of dose on the disposition kinetics of netilmicin in the isolated kidney of the rat.Adaptation to flavomycin in the ruminal bacterium, Prevotella bryantii.Modeling the emergence of antibiotic resistance in the environment: an analytical solution for the minimum selection concentration.Amikacin Pharmacokinetic-Pharmacodynamic (PK-PD) Analysis in Pediatric Cancer Patients.Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.Conditional probability analysis of multidrug resistance in Gram-negative bacilli isolated from tertiary medical institutions in South Korea during 1999-2009.Aminoglycoside dosing: time to change.Protection of Salmonella by ampicillin-resistant Escherichia coli in the presence of otherwise lethal drug concentrations.
P2860
Q33722011-95CD3803-F26E-45B4-A96D-E31D29473ECEQ33827819-32A23200-D577-4EBC-A762-FE26D750A9ADQ35005112-8D3A6216-D600-434C-A994-C11FE532AB42Q35124853-72DE2C49-A2FB-46F7-88DF-7894EE544564Q35135145-35FB3745-85E2-42D2-8C70-1BB733E09878Q35579733-66E95B13-469F-4BC2-87A1-E15B93A31B85Q35819487-5D440795-3BBC-4C0F-BB99-FA52B834E89EQ35926193-3A5C8546-33EF-44B4-BA5E-8CDAF981D42BQ36021296-2190D766-CA87-4999-9185-F711E52794CCQ36365374-3DD2E0C7-7339-4035-906D-E7C0A22DB8D6Q36508695-8F502EAD-11F6-4CAB-BE90-142F50D3C013Q37643058-8168059E-A09E-4543-BE52-6E3FDAF70C4EQ37956403-6B1DBC1F-02A6-4A22-8739-62A818FA9B24Q38626980-4315B2BB-49FE-47DE-BE2E-929F1DA7C15EQ38814607-0060CF52-25E1-463D-A3D2-843AD4A0DE68Q38983244-0D263138-B97C-4ED7-BE92-7965A17FCC87Q39679087-21401BD5-B263-4E2B-841D-5E36D710F92AQ39743310-1CFD0305-0FEF-4C93-BF8C-77A125CCB986Q39778914-783FB995-3EC8-4AF3-93CD-7F6F8B8E78FCQ39781139-D1EA51CE-ED03-48E4-8E6D-D713F68DE258Q40286774-48CEF41E-7FDF-4A0A-8985-1648291DAD89Q40326667-126DF72A-2695-43EA-BC65-FE3307697E2BQ40949882-3A82513A-BD1C-4B22-83BD-F2D79753697FQ40949894-BA7EB624-ED6B-45A7-8446-05D2A289B0F6Q41877860-2F4AE42E-FBC5-40DE-8A15-4933D897DBBDQ42545727-493F45B4-B9A6-47B6-9AA1-CDB4F9AAA489Q42717931-84393275-78D7-483E-A90B-C9BB04C6B8DCQ43355746-96EA11DD-BF38-47FA-A6CA-87C126BAE8A2Q43872720-3458922A-BA31-4132-A171-CC4F50E3381CQ44027608-98628C9B-BAD8-4789-BCCB-1E37FED8ACE1Q46808899-61C4DC49-00F8-4064-97B6-E17F18D17433Q47273948-7B135CD0-2849-4684-918D-767F7648CEEEQ48528055-570B8737-ACA8-449A-BCA3-A3CE3A154FDBQ51930719-604FE1C6-3169-475E-96A9-20CE7F0F857AQ53802828-80E69C64-F4EC-4D69-B704-F8EDA1E6B87CQ54198578-C05725B8-DE1C-4BBD-85DB-BD46CB2E844FQ54400707-920DBC66-9D4D-4D15-90AC-BC49CB51FD67
P2860
Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.
@en
Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.
@nl
type
label
Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.
@en
Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.
@nl
prefLabel
Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.
@en
Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.
@nl
P2860
P356
P1476
Adaptive resistance following single doses of gentamicin in a dynamic in vitro model
@en
P2093
P2860
P304
P356
10.1128/AAC.36.9.1951
P407
P577
1992-09-01T00:00:00Z